• To be able to perform specialist assessment, treatment and counselling of patients with Hodgkin's lymphoma (HL)

  • Awareness of the existence of different pathological subtypes of HL

  • Appreciation of the availability of different diagnostic approaches

  • Awareness of the existence of different prognostic factors in HL

  • Appreciation of the importance of the multimodality approach to treat patients with HL depending on stage

  • Appreciation of the principles of the multimodality approach with early-stage or bulky disease

  • Appreciation of the importance of late effects that may affect patients with HL depending on treatment type

  • Familiarity with the characteristics of the different pathological subtypes of HL, including classical HL and nodular lymphocyte-predominant HL

  • Familiarity with the indications for, expectations from and limitations of the different diagnostic approaches available for the identification of HL, including excisional biopsy versus core needle biopsy and immunophenotypic profile

  • Familiarity with the staging system for HL

  • Understanding of the role of the prognostic factors which guide treatment selection in HL

  • Understanding of the role of positron emission tomography (PET) imaging in the staging and restaging of HL and its limitations

  • Familiarity with the indications for and the value of radiation therapy, chemotherapy, supportive and palliative care, and survivorship care in HL

  • Understanding of the role of high-dose chemotherapy and/or bone marrow/stem cell transplantation in relapsed and refractory HL

  • Understanding of the role of monoclonal antibody therapy in the relapsed/refractory setting

  • Familiarity with the treatment approach of HL during pregnancy, in older or frail patients, and in patients with human immunodeficiency virus (HIV)

  • Understanding of the early-stage and advanced stage setting as well as the bulky disease particularities

  • Ability to contribute actively to a variety of HL clinical scenarios and patient presentations

  • Ability to discuss critically the treatment options/recommendations

  • Ability to perform a history and physical examination in HL patients

  • Ability to use effectively the prognostic factors in order to guide treatment selection in HL

  • Ability to contribute to discussions on general management strategies in order to understand all the considerations on which treatment to use and when to incorporate radiation therapy

  • Ability to prescribe various chemotherapeutic regimens

  • Ability to manage side effects of various chemotherapeutic agents

  • Ability to discuss survivorship care and the risk for late treatment effects with patients